Status:
COMPLETED
The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane
Lead Sponsor:
CHU de Reims
Conditions:
Vitrectomy
Macular Thinning
Eligibility:
All Genders
18+ years
Brief Summary
Comparison between intravitreous glucose rate and macular thinning measured by Ocular Coherence Tomography (OCT) at 3 months post vitrectomy for retinal detachment or epimacular membrane. Hypothesis :...
Detailed Description
Comparison between intravitreous glucose rate and macular thinning measured by OCT at 3 months post vitrectomy for retinal detachment or epimacular membrane. The cohort is divided in 2 groups, one wit...
Eligibility Criteria
Inclusion
- patient who underwent vitrectomy for retinal detachment or epimacular membrane
Exclusion
- patient suffering of diabetes,
- recurrence of retinal detachment,
- age-related macular degeneration,
- post surgical macular oedema
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02210481
Start Date
February 1 2014
End Date
December 1 2014
Last Update
November 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Reims
Reims, France, 51100